A high-yielding CHO transient system: coexpression of genes encoding EBNA-1 and GS enhances transient protein expression
Abstract
An efficient rapid protein expression system is crucial to support early drug development. Transient gene expression is an effective route, and to facilitate the use of the same host cells as for subsequent stable cell line development, we have created a high‐yielding Chinese hamster ovary (CHO) transient expression system. Suspension‐adapted CHO‐K1 host cells were engineered to express the gene encoding Epstein‐Barr virus (EBV) nuclear antigen‐1 (EBNA‐1) with and without the coexpression of the gene for glutamine synthetase (GS). Analysis of the transfectants indicated that coexpression of EBNA‐1 and GS enhanced transient expression of a recombinant antibody from a plasmid carrying an OriP DNA element compared to EBNA‐1‐only transfectants. This was confirmed with the retransfection of an EBNA‐1‐only cell line with a GS gene. The retransfected cell lines showed an increase in transient expression when compared with that of the EBNA‐1‐only parent. The transient expression process for the best CHO transient cell line was further developed to enhance protein expression and improve scalability by optimizing the transfection conditions and the cell culture process. This resulted in a scalable CHO transient expression system that is capable of expressing 2 g/L of recombinant proteins such as antibodies. This system can now rapidly provide gram amounts of recombinant antibody to supply preclinical development studies that has comparable product quality to antibody produced from a stably transfected CHO cell line. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 30:132–141, 2014
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The production rate in transient transfection relies on many factors including efficiency of the transfection phase, cytotoxicity of the transfection reagent, and extensiveness of the feeding strategy applied post-transfection.
“However, the production rate relies on many factors including efficiency of the transfection phase, cytotoxicity of the transfection reagent and extensiveness of the feeding strategy applied to the culture post-transfection (Pham et al., 2006;Daramola et al., 2014).”
From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Daramola et al., 2014
Cites
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1932 · Cited by 785 · see citing works
Large-Scale transfection of mammalian cells for the fast production of recombinant protein
Pham, P. L., Kamen, A., & Durocher, Y. (2006) · Molecular Biotechnology · doi:10.1385/mb:34:2:225 · Cited by 236 · see citing works
Rosser, M. P., Xia, W., Hartsell, S., McCaman, M., Zhu, Y., Wang, S., Harvey, S., Bringmann, P., & Cobb, R. R. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2004.07.015 · Cited by 68 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Therapeutic glycoprotein production in mammalian cells
Lalonde, M.-E., & Durocher, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.028 · Cited by 296 · see citing works
Popovic, B., Breed, J., Rees, D. G., Gardener, M. J., Vinall, L. M. K., Kemp, B., Spooner, J., Keen, J., Minter, R., Uddin, F., et al. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.12.005 · Cited by 198 · see citing works
Computational design of epitope-specific functional antibodies
Nimrod, G., Fischman, S., Austin, M., Herman, A., Keyes, F., Leiderman, O., Hargreaves, D., Strajbl, M., Breed, J., Klompus, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.081 · Cited by 77 · see citing works
Wang, C., van Haperen, R., Gutiérrez-Álvarez, J., Li, W., Okba, N. M. A., Albulescu, I., Widjaja, I., van Dieren, B., Fernandez-Delgado, R., Sola, I., et al. (2020) · doi:10.1101/2020.10.20.346916 · Cited by 15 · see citing works
Self-citationPapworth, M., Kulkarni, S., Antonsson, M., Sermadiras, I., Hovdal, D., Connolly, K., Olsson, J., Shukla, A., Cotton, P., Althage, M., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf031 · Cited by 8 · see citing works
- Authors
- Daramola, O., Stevenson, J., Dean, G., Hatton, D., Pettman, G., Holmes, W., & Field, R.
- Affiliations
- Cell Sciences Biopharmaceutical Development, MedImmune Cambridge CB21 6GH U.K.
- Corresponding author
- Daramola, Olalekan
- ORCID
- Hatton, Diane
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2013-10-10
- Volume
- 30
- Issue
- 1
- Pages
- 132-141
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2032901225
- Cited by
- 134
- References
- 3
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 12 · 2023: 4 · 2022: 7 · 2021: 11 · 2020: 6 · 2019: 11 · 2018: 17 · 2017: 17 · 2016: 17 · 2015: 15 · 2014: 6 · 2013: 1
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology Progress (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- transient protein expression, CHO-K1 cells, EBNA1, glutamine synthetase, co-expression, oriP, recombinant antibody production, transfection optimization, preclinical drug development, cell suspension culture
- MeSH terms
- Analysis of Variance, Animals, Antibodies, Monoclonal, Cricetulus, Glutamate-Ammonia Ligase, Cricetinae, Polyethyleneimine, Recombinant Proteins, CHO Cells, Epstein-Barr Virus Nuclear Antigens, Cell Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review